Naltrexone And Bupropion
Pharmacological and Behavioral Treatment After Bariatric Surgery
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 84
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| BWL + NB medication | Obesity or overweight | n/r | n/r | n/r | n/r |
| BWL + Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| NB medication | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |